< Back to latest news & events

Event

Arab Health 2020 – Dubai

January 2020

Event date: 27th January 2020

HGF will be exhibiting at Arab Health 27th – 30th Jan 2020 in Dubai. Arab Health is the largest gathering of healthcare and trade professionals in the MENA (Middle East, North African) region.

Visit the HGF stand – Hall 2 stand D32.

HGF Partners Vanessa Stainthorpe and Kieran Killough will be attending Arab Health 27th – 30th Jan 2020. They will be available throughout the conference to offer their expert advice on how you can protect, exploit and defend your intellectual property assets.

To arrange a meeting please email Anita O’Neil at [email protected] advising of your preferred day, time and location.

Arab Health 2020 takes place at Dubai World Trade Centre from 27th – 30th Jan 2020 and is expected to welcome more than 4,250 exhibiting companies and over 55,000 attendess from 159 countries.

For more information on Arab Health visit www.arabhealthonline.com.

Attendees

Vanessa
Stainthorpe

Latest updates

Polymorphs: Clearing the Inventive Step Hurdle at the European Patent Office (EPO)

Polymorphic forms of active pharmaceutical ingredients (APIs) can represent commercially valuable compound subject matter and can be critical to providing necessary drug product characteristics and performance. However, patenting polymorphs is …

Read article

IQPC Global US Exchange

HGF are proud ‘Silver Plus’ sponsors of the IQPC Global US Exchange, at the Austin Marriot South, Texas. The IQPC Global US Exchange will be held at the Austin Marriot …

Read article

Update on the Precision Breeding Act 2023: details emerge of the new simplified regulatory pathway for gene edited plant and animal derived food and feed products

The Genetic Technology (Precision Breeding) Act 2023 could come into force as early as spring 2025. It empowers the Food Standards Agency (FSA) to create a new simplified regulatory pathway …

Read article

Court of Appeal Decision Upholds Invalidity of Patent Due to Amendment Identifying Embodiment as Outside the Scope of the Claims

In a case that highlights the challenges arising due to post-grant amendments, and in particular interpretation of the claims in view of the description, the Court of Appeal in Ensygnia …

Read article

UPC Court of Appeal clarifies approach for interpreting claims with “obvious” errors

Alexion Pharmaceuticals, Inc. v Samsung Bioepis NL B.V. [UPC_CoA_402/2024] –Court of Appeal of the UPC (Grabinski, Blok, Gougé, Enderlin, Hedberg) – 20 December 2024 Alexion Pharmaceuticals, Inc. v Amgen Technology …

Read article

IP Ingredients: Winter Case Law Review 2024

As the nights draw in and the frenzy to finish everything off before the holiday season reaches its peak, it’s time to take a break, grab your favourite hot beverage …

Read article
See all updates